Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-028742

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Keith D Dawkins
Officer — EVP, Global Chief Med. Off.
Period of report
Feb 27, 2016
Accepted (ET)
Mar 1, 2016 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 27, 2016M4,777$0.00A227,086D
Common StockFeb 27, 2016F2,150$17.21D224,936D
Common StockF1Feb 28, 2016M4,887$0.00A229,823D
Common StockF1Feb 28, 2016M4,736$0.00A234,559D
Common StockFeb 28, 2016F4,332$17.21D230,227D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF3,F1,F2—Feb 27, 2016M4,777D——Common Stock4,77723,872D
Deferred Stock UnitsF3,F1,F4—Feb 28, 2016M4,736D——Common Stock4,73619,136D
Deferred Stock UnitsF3,F1,F5—Feb 28, 2016M4,887D——Common Stock4,88714,249D

Explanation of responses